Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.
about
The life and times of the EnterococcusPlasmids, drug resistance, and gene transfer in the genus Streptococcus.A new high-level gentamicin resistance gene, aph(2'')-Id, in Enterococcus spp.Prophylaxis against enterococcal endocarditis: comparison of the aminoglycoside component of parenteral antimicrobial regimensAminoglycoside resistance in enterococci.Conjugative transfer of multiple antibiotic resistance markers in Streptococcus pneumoniae.Common bacterial pathogens and resistance to antibiotics.Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci.Mechanisms of antibiotic resistance in enterococci.Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin.High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci.Conjugative R plasmids in Streptococcus faecium (group D).Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbitsRoles of antibodies and complement in phagocytic killing of enterococciBactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinationsCharacterization of two tetracycline resistance determinants in Streptococcus faecalis JH1Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?The rise of the Enterococcus: beyond vancomycin resistance.The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis.Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?The use of platensimycin and platencin to fight antibiotic resistance.Emergence and management of drug-resistant enterococcal infections.Antimicrobial resistance among enterococci.Screening and treatment of infections caused by resistant enterococci.Enterococcal endocarditis revisited.The enterococcus.Multiplex PCR for detection of aminoglycoside resistance genes in enterococci.Molecular epidemiology of beta-lactamase-producing enterococci.High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.Antagonistic effect of penicillin-amikacin combinations against enterococci.Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.Enterococcus, an emerging pathogen.Ribosomal resistance of clinical enterococcal to streptomycin isolates.Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides.Antibiotic synergism--lessons from the enterococcus.Enterococcus faecalis resistance to drugs: recent trends and development of high-level resistance to aminoglycosides.
P2860
Q24616875-6B431571-93F3-42B8-800D-F3D78CCB8832Q33625512-85063E68-EEBF-4635-B733-033E6612C019Q33695820-75318D9A-0757-4E77-B68F-C854C7797116Q33733336-15A66B87-3D66-4A88-A1D8-42C93D54CFBEQ34033627-AB9771C0-EB56-467D-A315-1653F690A5FDQ34141016-F760EB7C-230A-4DAC-9614-9031C80E5C85Q34553146-E6E2BD0A-9CD1-463B-9567-0D0832E8C7C6Q35269724-CE4F771B-51B6-4B7E-9D2F-02C775D6EC1DQ35610646-BF0D1CDA-E633-48FA-85F1-1A5972867467Q35669249-9C024DA5-A8AB-4B5E-A6B6-2BBD5EF89AEBQ35673429-14471D56-2733-4347-AC88-0109E128878CQ35675576-DBD056D5-46C5-4C8E-BB61-B063ABCD6C30Q35754987-BD6AAD69-4BC2-46FB-B611-E0A4171A168BQ35775214-24FFD018-A240-432A-A685-3B6CE5CD80E3Q35821314-28E4860F-4DE5-404B-8170-5925DD17C930Q36310214-04DD2AEC-FB4E-4978-8AC4-34BBE2F907CEQ36546820-728F639F-EBA8-42F4-9E74-C70C1DB4BB97Q36752156-A936DD0B-B7AF-484C-AEAB-CBA472B13ADFQ36988568-9561E162-BCD1-4EFC-8B4E-668563B52613Q37143562-FD420F07-8235-4FF7-8275-324FB1918F28Q37180294-EE2B140D-6BB7-4003-AE75-EF5E54A73C85Q37203095-B865FDD9-D1C3-4EB9-B5AD-F0973BE5D014Q37291346-3CBB80F1-86AB-4C72-9BB3-8FBE2764B716Q37328448-375C4A3E-D556-4B5E-939B-42EE47A6BFFDQ37711795-C859593D-351E-451B-9A11-8449CC2E3D92Q38539279-77DBEDCD-D8AF-42B9-AA16-C89AB78A9096Q39592494-2D68FFCA-539A-4742-B835-7FE878D34787Q39743479-A4889392-3817-4406-AF67-1BE80CB9D56CQ39815390-A99D1293-BFD8-45C1-881D-85CC1AEEAD26Q39832488-D46F87E4-372D-4112-9231-BB8622A9F905Q39834106-B4D5A050-308A-4F4F-B06C-0098050E787DQ40212219-EEAECA34-E186-451F-8BDE-7214002FCB76Q40785841-6AEF8285-C9F7-45EA-84D1-E18117D06692Q41850140-9C432210-1D56-4E86-BBF4-44F7A4EF571CQ42093045-D345F928-D721-432D-AA69-D2FB07F6CA73Q43094334-02894DE0-FD7F-4959-9F65-101F303412B6Q54348547-C31AE7DB-BF14-4EBF-9329-E4C6E490F66E
P2860
Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@en
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@nl
type
label
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@en
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@nl
prefLabel
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@en
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@nl
P2093
P2860
P356
P1476
Aminoglycoside-inactivating en ...... tance to antibiotic synergism.
@en
P2093
Korfhagen TR
Krogstad DJ
Moellering RC Jr
Wennersten C
P2860
P304
P356
10.1172/JCI109149
P407
P577
1978-08-01T00:00:00Z